Cytotoxic T cells recognize cancer cells through the presentation of tumor-associated antigens (TAAs) on MHC class I molecules. When a cytotoxic T cell's TCR binds to a TAA-MHC complex, it triggers an immune response. The specificity of the TCR ensures that only cells presenting the specific antigen are targeted, making this a precise mechanism for identifying and eliminating cancer cells.
